Ignite Creation Date:
2024-05-05 @ 5:21 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00435396
Status:
COMPLETED
Last Update Posted:
2017-05-30
First Post:
2007-02-14
Brief Title:
Study to Evaluate Safety and Immunogenicity of the GSK Bio CMV Vaccine in CMV-seronegative Healthy Male Adult Subjects
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-02-22
Start Date Type:
ACTUAL
Primary Completion Date:
2008-08-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-08-27
Completion Date Type:
ACTUAL
First Submit Date:
2007-02-14
First Submit QC Date:
February 14 2007
Study First Post Date:
2007-02-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-05-24
Last Update Post Date:
2017-05-30
Last Update Post Date Type:
ACTUAL